Search published articles


Showing 2 results for Gentamicin

Poran Toolabi, Majid Tavafi , Soheila Ebrahimi, Sima Nasri, Hasan Ahmadvand ,
Volume 13, Issue 3 (12-2011)
Abstract

Background : Administration of Gentamicin is restricted due to its nephrotoxicity. Many studies have demonstrated that free radicals induced Gentamicin- nephrotoxicity. Olive leaf contains some antioxidant biophenols such as Oleuropin. In this study for the first time the effect of hydroalcohlic olive leaf extract on Gentamicin-induced nephrotoxicity was investigated. Materials and Methods: 35 male Sprague-Dowley rates were randomly divided into five groups. The first group served as a control and injected with the normal saline. Nephrotoxicity induced by Gentamicin (100 mg/kg) in experimental groups for 12 days. Three groups were treated with hydroalcohlic olive leaf extract (25, 50 and 100 mg/kg respectively). The rats were killed on the twelfth day.Plasma Malondialdehyde (MDA) and creatinine concentrations were measured. Kidney sections were prepared and stained with PAS method for histopathological studies. Results: hydroalcohlic olive leaf extract at 25, 50 and 100 mg/kg/d significantly reduced gentamicin-induced tubular necrosis (p<0.05) and inhibited decreases of proximal tubule volume density (p<0.05). hydroalcohlic olive leaf extract at 50 and 100 mg/kg/d significantly reduced lymphocyte infiltration in comparison with Gentamicin administrated rats (p<0.05). Gentamicin increased level of MDA. Treatment with extract (100 mg/kg/d), significantly reduced level of MDA compared with other groups (p<0.05).Use of extract at 25, 50 and 100 mg/kg/d significantly inhibited increase of serum creatinine (p<0.001). Treatment with extract (50 mg/kg/d), significantly inhibited increase of serum urea (p<0.05). Conclusion: Hydroaleohlic olive leaf extract can reduce Gentamicin-induced nephrotoxicity and this effect is probably depends on antioxidant properties of this extract.
Zahra Atefi, Nadia Kazemipour,
Volume 26, Issue 1 (4-2024)
Abstract

Background: Staphylococcus aureus is an opportunistic pathogen that plays a role in hospital infections. Due to the ability of this bacteria to produce biofilm, its antibiotic resistance has increased. Silver nanoparticles (AgNPs), due to their small size, can penetrate bacterial cells and destroy the bacterial biofilm. The present study aimed to investigate the anti-biofilm effect of AgNPs and gentamicin on clinical Staphylococcus aureus.
Materials and Methods: Staphylococcus aureus isolates were collected from health centers in Kerman, Iran, and identified by biochemical tests. The antibiotic resistance of the isolates was evaluated against antibiotics, and then, the minimum inhibitory concentration (MIC) of the isolates was assessed by gentamicin and AgNPs. Bacterial isolates were exposed to 2 MIC, 1 MIC, ½ MIC, and ¼ MIC of gentamicin and AgNPs separately, and the results were compared.
Results: The 100% resistance of isolates to oxacillin and penicillin antibiotics was observed, and the resistance percentages 63.33%, 6.66%, and 3.33% to tetracycline, ciprofloxacin and gentamicin, respectively, were confirmed. The MIC of the isolates was from 64 μg/ml to 32 μg/ml against gentamicin, and it was from 10.62 ppm to 5.31 ppm against AgNPs. Comparing the anti-biofilm effect of AgNPs and gentamicin at 1 MIC, ½ MIC, and ¼ MIC, there was a significant difference at the 5% probability level, and the anti-biofilm effect of AgNPs was better than gentamicin.
Conclusion: According to the obtained results, it is suggested that AgNPs be used to control and destroy the biofilms formed by Staphylococcus aureus with further research.


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Yafteh

Designed & Developed by : Yektaweb